Keywords: Sanofi, Fourth-quarter and full year 2011 financial results, Plavix damages, Apotex, Bristol-Myers

Sanofi fourth-quarter in line with forecasts; collects damages

Article | 08 February 2012

French drug major Sanofi (Euronext: SAN) this morning reported 8.8% growth in fourth-quarter 2011 sales to 8.51 billion euros ($11.16 billion), in-line with consensus ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Apotex

Bristol-Myers Squibb

Go to company listing

Related Drugs

Plavix

Go to drug listing